Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson's disease.
作者信息
Ackermann H, Ziegler W, Oertel W H
机构信息
Department of Neurology, University of Tübingen, Federal Republic of Germany.
出版信息
J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):805-7. doi: 10.1136/jnnp.52.6.805.
Abstract
摘要
相似文献
1
Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson's disease.复述言语作为帕金森病中左旋多巴诱发运动障碍的一种症状。
J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):805-7. doi: 10.1136/jnnp.52.6.805.
2
[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
Lakartidningen. 1993 Apr 21;90(16):1545-8.
3
4
The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.悉尼帕金森病多中心研究：头3年的报告
J Neurol Neurosurg Psychiatry. 1989 Mar;52(3):324-8. doi: 10.1136/jnnp.52.3.324.
5
Low dosages of bromocriptine added to levodopa in Parkinson's disease.帕金森病中，低剂量溴隐亭与左旋多巴联合使用。
Neurology. 1985 Feb;35(2):199-206. doi: 10.1212/wnl.35.2.199.
6
Seven-year follow-up study of bromocriptine therapy for Parkinson's disease.溴隐亭治疗帕金森病的七年随访研究
Eur Neurol. 1994;34 Suppl 3:29-35. doi: 10.1159/000119539.
7
[Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].左旋多巴和卡比多巴治疗帕金森综合征（作者译）
MMW Munch Med Wochenschr. 1976 May 14;118(20):653-6.
8
[Secondary effects of prolonged levodopa therapy in Parkinson's disease].[帕金森病长期左旋多巴治疗的继发效应]
Med Clin (Barc). 1985 Jun 15;85(3):88-91.
9
[The treatment of Parkinson disease using the combination bromocriptine and levodopa].
Rev Med Suisse Romande. 1990 Jun;110(6):559-64.
10
[Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Nervenarzt. 1981 Feb;52(2):116-20.
引用本文的文献
1
Levodopa-Associated Barking Vocalizations.左旋多巴相关的吠叫声
J Mov Disord. 2021 May;14(2):164-165. doi: 10.14802/jmd.20086. Epub 2020 Oct 31.
2
Effect of Levodopa on Speech Dysfluency in Parkinson's Disease.左旋多巴对帕金森病言语不流畅的影响。
Mov Disord Clin Pract. 2018 Dec 30;6(2):150-154. doi: 10.1002/mdc3.12714. eCollection 2019 Feb.
3
Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study.多巴胺能药物对帕金森病言语不流畅的影响：一项纵向研究。
J Neural Transm (Vienna). 2015 Aug;122(8):1135-42. doi: 10.1007/s00702-015-1363-y. Epub 2015 Jan 13.
4
A review of brain circuitries involved in stuttering.口吃相关脑回路综述。
Front Hum Neurosci. 2014 Nov 17;8:884. doi: 10.3389/fnhum.2014.00884. eCollection 2014.
5
Repetitive speech phenomena in Parkinson's disease.帕金森病中的重复言语现象。
J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):319-24. doi: 10.1136/jnnp.69.3.319.
本文引用的文献
1
Palilalia: a descriptive study of pathological reiterative utterances.重复言语：病理性重复话语的描述性研究
J Speech Hear Disord. 1981 Feb;46(1):34-8. doi: 10.1044/jshd.4601.34.
2
Acoustic properties of pathologic reiterative utterances: a case study of palilalia.病理性重复言语的声学特性：一例言语反复症的案例研究
J Speech Hear Res. 1982 Mar;25(1):95-9. doi: 10.1044/jshr.2501.95.
3
Interruption of phonological coding in conduction aphasia.传导性失语中语音编码的中断。
Brain Lang. 1984 Jul;22(2):266-91. doi: 10.1016/0093-934x(84)90094-4.
4
[The L-dopa test in Parkinson's disease].[帕金森病的左旋多巴试验]
Rev Neurol (Paris). 1985;141(5):413-5.
5
Site of penetrating brain lesions causing chronic acquired stuttering.导致慢性获得性口吃的穿透性脑损伤部位。
Ann Neurol. 1987 Jul;22(1):60-6. doi: 10.1002/ana.410220114.
6
Palilalia.重复言语
Br J Disord Commun. 1975 Oct;10(2):92-7. doi: 10.3109/13682827509011280.
7
Stuttering following brain damage.
Brain Lang. 1978 Jul;6(1):82-96. doi: 10.1016/0093-934x(78)90046-9.
Zotero 插件